标题 |
Prospective, randomized, controlled, double-blind clinical study of traditional Chinese medicine combined with glucocorticoid in the treatment of generalized myasthenia gravis
中药联合糖皮质激素治疗全身性重症肌无力的前瞻性随机对照双盲临床研究
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | INTERVENTION: Treatment group:Traditional Chinese medicine compound glucocorticoid;control group:glucocorticoid; CONDITION: Myasthenia Gravis PRIMARY OUTCOME: the relapse rate after hormone reduction,The incidence rate of hormone complications,and conversion rate of Myasthenia gravis crisis;Myasthenia gravis quantitative score (qMGS),;myasthenia gravis complex scale (MGC);myasthenia gravis muscle scale (MMS);myasthenia gravis absolute and relative score (ARS‐MG); SECONDARY OUTCOME: MG daily life scale (MG‐ADL); INCLUSION CRITERIA: 1. The first onset meets the diagnostic criteria for generalized myasthenia gravis; 2. Complete admission data, detailed condition description, complete disease course record and no obvious missing items; 3. Application of glucocorticoid therapy; 4. Aged over 18 years old; 5. The diagnosis of GMG was re‐verified by at least two attending physicians or higher‐level physicians based on typical clinical phenotypes and laboratory test results. |
求助人 | |
下载 |